Realized impact of COVID ‐19 related disruptions on the National Bowel Cancer Screening Program
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.18894 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Matthew P Irwin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Bankstown-Lidcombe Hospital, South Western Sydney Local Health District, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: COVID-19, Colorectal Neoplasms, Early Detection of Cancer, Colonoscopy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Colorectal cancer is the second most common cause of cancer mortality in Australia (1). The National Bowel Cancer Screening Program (NBCSP) aims to reduce mortality through early detection with a biennial faecal occult blood test for Australians aged 50–74 years (2). Modelling predicted COVID‐19 would reduce participation and delay colonoscopies despite the NBCSP continuing during the pandemic (3). This study analyses the realized impact of COVID‐19 related disruptions on the NBCSP and the effect on mortality.
Methods
NBCSP participation, time to colonoscopy and annualized mortality were compared before and during COVID‐19. The effect on mortality was determined using a validated microsimulation model (4, 5).
Results
From 1 January 2018 to 31 December 2019, 2 497 317 people participated in the NBCSP and 168 390 received a colonoscopy, compared to 2 490 265 and 162 573 from 1 January 2020 to 31 December 2021. Relative participation decreased 6 % and the proportion of colonoscopies performed within the recommended 120 days increased 14.5%. A disproportionally greater impact was observed outside major cities and in lower socioeconomic areas. An estimated 98–111 additional colorectal cancer deaths resulted from 3 % fewer colonoscopies performed during the pandemic.
Conclusion
This study presents the most comprehensive analysis of the realized impact of COVID‐19 on the NBCSP. Catch‐up screening would be best targeted at Australians from rural and lower socioeconomic areas where participation remains low. Streamlined referral pathways and additional colonoscopy provisioning is required as less than two thirds of screen positive patients receive a colonoscopy within the recommended 120 days.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Bankstown-Lidcombe Hospital, South Western Sydney Local Health District, Sydney, New South Wales, Australia.
- School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
- School of Medicine, University of Sydney, Sydney, New South Wales, Australia.
- Royal Australian College of General Practitioners, Melbourne, Victoria, Australia.
- Department of Surgery, Wyong Hospital, Central Coast Local Health District, Gosford, New South Wales, Australia.
ORCID-Profile: Matthew P Irwin, Maxwell A Jambor
Zitieren
APA
Irwin, M. P., Dutta, T., Jambor, M. A., Morgan, M. J., Turner, C. E., & Liang, Y. (2024). Realized impact of COVID ‐19 related disruptions on the National Bowel Cancer Screening Program. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18894
Vancouver
Irwin MP, Dutta T, Jambor MA, Morgan MJ, Turner CE, Liang Y. Realized impact of COVID ‐19 related disruptions on the National Bowel Cancer Screening Program. ANZ Journal of Surgery. 2024. doi:10.1111/ans.18894
BibTeX
@article{Irwin2024,
author = {Irwin, Matthew P and Dutta, Trisha and Jambor, Maxwell A and Morgan, Matthew J and Turner, Catherine E and Liang, Yicong},
title = {Realized impact of COVID ‐19 related disruptions on the National Bowel Cancer Screening Program},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.18894}
}
EUVIMED